» Articles » PMID: 7551218

A Compendium of Vaccine Adjuvants and Excipients

Overview
Specialty Biotechnology
Date 1995 Jan 1
PMID 7551218
Citations 27
Authors
Affiliations
Soon will be listed here.
Citing Articles

In silico designing of novel epitope-based peptide vaccines against HIV-1.

Heidarnejad F, Namvar A, Sadat S, Moradi Pordanjani P, Rezaei F, Namdari H Biotechnol Lett. 2024; 46(3):315-354.

PMID: 38403788 DOI: 10.1007/s10529-023-03464-x.


Immunogenicity of Different Types of Adjuvants and Nano-Adjuvants in Veterinary Vaccines: A Comprehensive Review.

Nooraei S, Sarkar Lotfabadi A, Akbarzadehmoallemkolaei M, Rezaei N Vaccines (Basel). 2023; 11(2).

PMID: 36851331 PMC: 9962389. DOI: 10.3390/vaccines11020453.


HIV-1 Env Does Not Enable the Development of Protective Broadly Neutralizing Antibodies in an Experimental Autoimmune Encephalomyelitis Mouse Model.

Siracusano G, Finardi A, Pastori C, Martinelli V, Furlan R, Lopalco L Front Immunol. 2021; 12:771359.

PMID: 34795677 PMC: 8593332. DOI: 10.3389/fimmu.2021.771359.


Nanoparticle or conventional adjuvants: which one improves immune response against Brucellosis?.

Yousefi S, Abbassi-Daloii T, Tahmoorespur M, Sekhavati M Iran J Basic Med Sci. 2019; 22(4):360-366.

PMID: 31168339 PMC: 6535204. DOI: 10.22038/ijbms.2019.31748.7642.


Outer Membrane Vesicles: Current Status and Future Direction of These Novel Vaccine Adjuvants.

Tan K, Li R, Huang X, Liu Q Front Microbiol. 2018; 9:783.

PMID: 29755431 PMC: 5932156. DOI: 10.3389/fmicb.2018.00783.